A brave new "old world" of RNANovember 22, 2004A new function for RNA, which further elucidates how genes are expressed and regulated, is described on the 25th of November issue of the journal Nature. In our world DNA is the hereditary basis for most living organisms. Genes are segments of DNA and it is the information contained in all the genes of an organism that, when translated into proteins, makes up the blueprint for the body structure and function. Gene expression (into proteins) is done in two steps: transcription, by which genetic information in DNA is converted into RNA and translation, which is the synthesis of proteins based on the instructions contained in the new made RNA (basically will be DNA ? RNA ? protein). Both processes are crucial for correct gene expression/protein production and corruption in either of them can lead to disease. Now Alexandre Teixeira and colleagues at Sir William Dunn School of Pathology, University of Oxford, UK and at The Wellcome Trust Sanger Institute, Cambridge, UK discovered that the end of transcription could be regulated by the RNA molecule itself, acting as an enzyme. Enzymes accelerate (catalyse) chemical reactions without being altered in the process and are extremely important for life reactions, many of which could not happen without enzymes. And although RNA can be created in the laboratory to behave as an enzyme (in which case it is called a ribozyme) very few examples exist in nature and almost none is found in complex organisms. This makes the results of the team of scientists, describing how a natural occurring ribozyme regulates termination of transcription, extremely exciting. Furthermore, by definition, transcription termination is directly associated with correct gene expression and any data that can lead to a better understanding of this process is especially important. Also, a question that has always puzzled scientists was why about 32% of the human genome/DNA, although transcribed into RNA, never leads to protein production (DNA ? RNA ? no protein). Why would evolution have allowed the conservation of such big quantities of apparently non-functional DNA/RNA? What recent research has unveiled is that RNA seems to have a much more important role in gene expression than previously thought and is not only a mere helper between DNA and proteins. In fact, some of that RNA which is not translated into proteins, has been shown to be involved in gene regulation or, like the one described in this paper, is capable of catalyzing a chemical reactions like an enzyme. This versatility leads back to the idea of an ancient "RNA world" where life was based on multifunctional self-replicating RNA molecules. Teixeira and colleagues' work give support to such hypothesis by showing that in humans there are ribozymes involved in key cellular reactions and maybe they were once capable of mediate all the processes necessary to sustain life. Work by Teixeira et al., showing that termination of transcription is regulated by a ribozyme, has important implications. In fact, the results by the team of scientists not only help our understanding of how gene expression is regulated, and consequently how incorrect gene expression can be controlled, but also contribute to the ongoing debate on the origin of life. Piece researched and written by: Catarina Amorim (catarina.amorim@linacre.ox.ac.uk) Observatório da CiÙncia e do Ensino Superior |
|||||||||||||||||||||
| Related DNA Current Events and DNA News Articles Deciphering the regulatory code Embryonic development is like a well-organised building project, with the embryo's DNA serving as the blueprint from which all construction details are derived. Male sabertoothed cats were pussycats compared to macho lions Despite their fearsome fangs, male sabertoothed cats may have been less aggressive than many of their feline cousins, says a new study of male-female size differences in extinct big cats. Autism Consortium symposium draws record number of researchers, advocates, parents for autism update The Autism Consortium, an innovative collaboration of researchers, clinicians, funders and families dedicated to catalyzing research and enhancing clinical care for autism spectrum disorders (ASDs), held its fourth annual symposium on October 28th, 2009, at Harvard Medical School in Boston. Researchers identify drug candidate for treating spinal muscular atrophy A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. Conserving historic apple trees The apple trees of yesteryear are slowly disappearing. Many apple varieties common in the United States a century ago can no longer be found in today's orchards and nurseries. Tiny injector to speed development of new, safer, cheaper drugs It's no bigger than a stamp packet but it has the potential to allow rapid development of a new generation of drugs and genetic engineering organisms, and to better control in-vitro fertilization. Taking aim at mysterious DNA structures in the battle against cancer Designers of anti-cancer drugs are aiming their arrows at mysterious chunks of the genetic material DNA that may play a key role in preventing the growth and spread of cancer cells, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine. Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers The white shark may be the ultimate loner of the ocean, cruising thousands of miles in a solitary trek, but a team of researchers has discovered that the sharks have maintained such a consistent pattern of migration that over tens of thousands of years the white sharks in the northeastern Pacific Ocean have separated themselves into a population genetically distinct from sharks elsewhere in the world. Clinical tests begin on medication to correct Fragile X defect NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. A Potential Anti-cancer Agent Pateamine A (PatA), a natural product first isolated from marine sponges, has attracted considerable attention as a potential anti-cancer agent, and now a new activity has been found for it, which may reveal yet another anti-cancer mechanism. More DNA Current Events and DNA News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||